Vito Turk

Personal Home Page

http://bio.ijs.si/director.htm

Articles in Scholarly Journals [Incomplete List]

  1. Interaction between Human Cathepsins K, L, and S and Elastins: MECHANISM OF ELASTINOLYSIS AND INHIBITION BY MACROMOLECULAR INHIBITORS
    Journal of Biological Chemistry, vol. 282, no. 11, pp. 7893–7902, 2007
  2. Presence of the propeptide on recombinant lysosomal dipeptidase controls both activation and dimerization
    Biological Chemistry, vol. 388, no. 1, pp. 47–51, 2007
  3. Lysosomal cysteine cathepsins: signaling pathways in apoptosis
    Biological Chemistry, vol. 388, no. 6, pp. 555–560, 2007
  4. Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
    Current Pharmaceutical Design, vol. 13, no. 3, pp. 385–401, 2007
  5. Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
    Current Pharmaceutical Design, vol. 13, no. 4, pp. 387–403, 2007
  6. Do lysosomes induce cell death?
    IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), vol. 58, no. 8, pp. 493–494, 2006
  7. Diversity and Evolution of the Thyroglobulin Type-1 Domain Superfamily
    Molecular Biology and Evolution, vol. 23, no. 4, pp. 744–755, 2006
  8. Metacaspases of : Possible candidates for programmed cell death mediators
    Molecular and Biochemical Parasitology, vol. 145, no. 1, pp. 18–28, 2006
  9. Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro
    Journal of Cellular Biochemistry, vol. 97, no. 6, pp. 1230–1240, 2006
  10. Cleavage of MAGI-1, a tight junction PDZ protein, by caspases is an important step for cell-cell detachment in apoptosis
    Apoptosis, vol. 12, no. 2, pp. 343–354, 2006
  11. Resistance of cathepsin L compared to elastase to proteolysis when complexed with the serpin endopin 2C, and recovery of cathepsin L activity?
    Biochemical and Biophysical Research Communications, vol. 340, no. 4, pp. 1238–1243, 2006
  12. Differential regulation of the intrinsic pathway of apoptosis in brain and liver during ageing
    FEBS Letters, vol. 580, no. 15, pp. 3739–3745, 2006
  13. Mouse stefins A1 and A2 (Stfa1 and Stfa2) differentiate between papain-like endo- and exopeptidases
    FEBS Letters, vol. 580, no. 17, pp. 4195–4199, 2006
  14. A novel caspase-7 specific monoclonal antibody
    Immunology Letters, vol. 98, no. 1, pp. 167–169, 2005
  15. Protein aggregation as a possible cause for pathology in a subset of familial Unverricht–Lundborg disease
    Medical Hypotheses, vol. 64, no. 5, pp. 955–959, 2005
  16. Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans
    FEBS Letters, vol. 579, no. 5, pp. 1285–1290, 2005
  17. Sensitization of stefin B-deficient thymocytes towards staurosporin-induced apoptosis is independent of cysteine cathepsins
    FEBS Letters, vol. 579, no. 10, pp. 2149–2155, 2005
  18. Developmental shift in the apostat: Comparison of neurones and astrocytes
    FEBS Letters, vol. 579, no. 27, pp. 6147–6150, 2005
  19. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues
    Experimental Cell Research, vol. 306, no. 1, pp. 103–113, 2005
  20. Biochemistry, vol. 44, no. 21, pp. 7757–7767, 2005
  21. In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1
    Protein Science, vol. 14, no. 10, pp. 2713–2722, 2005
  22. Lysosomal Cysteine Proteases: Structural Features and their Role in Apoptosis
    IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), vol. 57, no. 4-5, pp. 347–353, 2005
  23. Inhibitory properties of cystatin F and its localization in U937 promonocyte cells
    FEBS Journal, vol. 272, no. 6, pp. 1535–1545, 2005
  24. Interaction of human stefin B in the prefibrillar oligomeric form with membranes. Correlation with cellular toxicity
    FEBS Journal, vol. 272, no. 12, pp. 3042–3051, 2005
  25. Differentiation- and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells
    Journal of Leukocyte Biology, vol. 78, no. 1, pp. 122–134, 2005
  26. Conformational Changes Preceding Amyloid-Fibril Formation of Amyloid- Beta, Prion Protein and Stefin B; Parallels in pH Dependence
    Medicinal Chemistry Reviews - Online, vol. 2, no. 4, pp. 359–367, 2005
  27. Dual concentration-dependent activity of thyroglobulin type-1 domain of testican: specific inhibitor and substrate of cathepsin L
    Biological Chemistry, vol. 386, no. 1, pp. 75–83, 2005
  28. hDLG/SAP97, a member of the MAGUK protein family, is a novel caspase target during cell-cell detachment in apoptosis
    Biological Chemistry, vol. 386, no. 7, pp. 705–710, 2005
  29. Human cathepsin F: expression in baculovirus system, characterization and inhibition by protein inhibitors
    Biological Chemistry, vol. 385, no. 6, pp. 505–509, 2004
  30. Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes
    Immunology, vol. 112, no. 3, pp. 378–385, 2004
  31. Cysteine cathepsins (proteases)?On the main stage of cancer?
    Cancer Cell, vol. 5, no. 5, pp. 409–410, 2004
  32. Novel aspartyl proteinase associated to fat body histolysis duringCeratitis capitata early metamorphosis
    Archives of Insect Biochemistry and Physiology, vol. 57, no. 2, pp. 51–67, 2004
  33. Effects of proteinase inhibitors on digestive proteinases and growth of the red flour beetle, Tribolium castaneum (Herbst) (Coleoptera: Tenebrionidae)
    Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol. 134, no. 4, pp. 481–490, 2003
  34. Biochemistry, vol. 42, no. 46, pp. 13522–13528, 2003
  35. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity
    Cell Death and Differentiation, vol. 10, no. 8, Article ID 4401247, 7 pages, 2003
  36. Human brain cathepsin H as a neuropeptide and bradykinin metabolizing enzyme
    Peptides, vol. 24, no. 12, pp. 1977–1984, 2003
  37. Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro
    Experimental Cell Research, vol. 283, no. 2, pp. 206–214, 2003
  38. Structural characterization of thyroglobulin type-1 domains of equistatin
    FEBS Letters, vol. 539, no. 1-3, pp. 120–124, 2003
  39. Selective Disruption of Lysosomes in HeLa Cells Triggers Apoptosis Mediated by Cleavage of Bid by Multiple Papain-like Lysosomal Cathepsins
    Journal of Biological Chemistry, vol. 279, no. 5, pp. 3578–3587, 2003
  40. Erratum
    Current Medicinal Chemistry, vol. 10, no. 1, pp. 97–97, 2003
  41. Nobuhiko Katunuma: An Outstanding Scientific and Professional Career of a Warm-Hearted Person. Reflections on the Occasion of his 75th Birthday
    Biological Chemistry, vol. 383, no. 5, pp. 723–724, 2002
  42. Amyloid Fibril Formation by Human Stefin B in vitro: Immunogold Labelling and Comparison to Stefin A
    Biological Chemistry, vol. 383, no. 5, pp. 859–863, 2002
  43. Apoptotic Pathways: Involvement of Lysosomal Proteases
    Biological Chemistry, vol. 383, no. 7-8, pp. 1035–1044, 2002
  44. Individual Recombinant Thyroglobulin Type-1 Domains Are Substrates for Lysosomal Cysteine Proteinases
    Biological Chemistry, vol. 383, no. 11, pp. 1809–1812, 2002
  45. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer
    Advances in Enzyme Regulation, vol. 42, pp. 285–303, 2002
  46. Human stefin B readily forms amyloid fibrils in vitro
    Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1594, no. 1, pp. 1–5, 2002
  47. A cathepsin D specific monoclonal antibody
    Immunology Letters, vol. 77, no. 2, pp. 125–126, 2001
  48. Amyloid fibril formation by human stefin B: influence of the initial pH-induced intermediate state
    Biochemical Society Transactions, vol. 30, no. 4, p. 543, 2001
  49. Biochemistry, vol. 40, no. 6, pp. 1671–1678, 2001
  50. Immunochemical Localisation of Cathepsin S, Cathepsin L and MHC Class II-Associated p41 Isoform of Invariant Chain in Human Lymph Node Tissue
    Biological Chemistry, vol. 382, no. 5, pp. 799–804, 2001
  51. Invasion of ras-Transformed Breast Epithelial Cells Depends on the Proteolytic Activity of Cysteine and Aspartic Proteinases
    Biological Chemistry, vol. 382, no. 5, pp. 853–857, 2001
  52. Anti-Cathepsin L Monoclonal Antibodies That Distinguish Cathepsin L from Cathepsin V
    Biological Chemistry, vol. 382, no. 5, pp. 867–870, 2001
  53. Lysosomal Protease Pathways to Apoptosis. CLEAVAGE OF Bid, NOT PRO-CASPASES, IS THE MOST LIKELY ROUTE
    Journal of Biological Chemistry, vol. 276, no. 5, pp. 3149–3157, 2001
  54. NEW EMBO MEMBERS' REVIEW: Lysosomal cysteine proteases: facts and opportunities
    The EMBO Journal, vol. 20, no. 17, pp. 4629–4633, 2001
  55. Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases
    The EMBO Journal, vol. 20, no. 23, pp. 6570–6582, 2001
  56. Major differences in stability and dimerization properties of two chimeric mutants of human stefins
    Proteins: Structure, Function, and Genetics, vol. 42, no. 4, pp. 512–522, 2001
  57. Significance of Cathepsin B Accumulation in Synovial Fluid of Rheumatoid Arthritis
    Biochemical and Biophysical Research Communications, vol. 283, no. 2, pp. 334–339, 2001
  58. The Major Cysteine Proteinase of Trypanosoma cruzi: A Valid Target for Chemotherapy of Chagas Disease
    Current Pharmaceutical Design, vol. 7, no. 12, pp. 1143–1156, 2001
  59. Structure-Based Development of Pyridoxal Propionate Derivatives as Specific Inhibitors of Cathepsin K in Vitro and in Vivo
    Biochemical and Biophysical Research Communications, vol. 267, no. 3, pp. 850–854, 2000
  60. Equistatin, a Protease Inhibitor from the Sea Anemone Actinia equina, Is Composed of Three Structural and Functional Domains
    Biochemical and Biophysical Research Communications, vol. 269, no. 3, pp. 732–736, 2000
  61. Cloning and Expression of Functional Equistatin
    Biological Chemistry, vol. 381, no. 1, pp. 85–88, 2000
  62. Recombinant Anti-Stefin A Fab Fragment: Sequence Analysis of the Variable Region and Expression in Escherichia coli
    Biological Chemistry, vol. 381, no. 12, pp. 1245–1249, 2000
  63. Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase
    European Journal of Biochemistry, vol. 267, no. 17, pp. 5404–5412, 2000
  64. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking
    British Journal of Cancer, vol. 82, no. 4, pp. 782–788, 2000
  65. Saxiphilin, a Saxitoxin-binding Protein with Two Thyroglobulin Type 1 Domains, Is an Inhibitor of Papain-like Cysteine Proteinases
    Journal of Biological Chemistry, vol. 275, no. 20, pp. 15572–15577, 2000
  66. A Procathepsin D specific monoclonal antibody that recognizes Procathepsin D but not Cathepsin D
    Immunology Letters, vol. 70, no. 3, pp. 211–212, 2000
  67. Lysosomal cysteine proteases: more than scavengers
    Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1477, no. 1-2, pp. 98–111, 2000
  68. Crystal structure of cathepsin X: a flip–flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease
    Structure, vol. 8, no. 3, pp. 305–313, 2000
  69. The high stability of cruzipain against pH-induced inactivation is not dependent on its C-terminal domain
    FEBS Letters, vol. 469, no. 1, pp. 29–32, 2000
  70. Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo
    FEBS Letters, vol. 458, no. 1, pp. 6–10, 1999
  71. Autocatalytic processing of recombinant human procathepsin B is a bimolecular process
    FEBS Letters, vol. 459, no. 3, pp. 358–362, 1999
  72. Thyroglobulin Type-1 Domains in Equistatin Inhibit Both Papain-like Cysteine Proteinases and Cathepsin D
    Journal of Biological Chemistry, vol. 274, no. 2, pp. 563–566, 1999
  73. Acidic pH as a physiological regulator of human cathepsin L activity
    European Journal of Biochemistry, vol. 259, no. 3, pp. 926–932, 1999
  74. Cathepsin S and Cruzipain Are Inhibited by Equistatin from Actinia equina
    Biological Chemistry, vol. 380, no. 5, pp. 589–592, 1999
  75. Mutational Analysis of Two Stefin A Epitopes
    Biological Chemistry, vol. 380, no. 6, pp. 723–726, 1999
  76. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S
    The EMBO Journal, vol. 18, no. 4, Article ID 7591514, 10 pages, 1999
  77. The p41 Fragment Story
    International Union of Biochemistry and Molecular Biology: Life, vol. 48, no. 1, pp. 7–12, 1999
  78. Differences in the effects of TFE on the folding pathways of human stefins A and B
    Proteins: Structure, Function, and Genetics, vol. 36, no. 2, pp. 205–216, 1999
  79. Inhibition Mechanism of Cathepsin L-Specific Inhibitors Based on the Crystal Structure of Papain–CLIK148 Complex
    Biochemical and Biophysical Research Communications, vol. 266, no. 2, pp. 411–416, 1999
  80. On the mechanism of human stefin B folding: I. Comparison to homologous stefin A. Influence of pH and trifluoroethanol on the fast and slow folding phases
    Proteins: Structure, Function, and Genetics, vol. 32, no. 3, pp. 296–303, 1998
  81. On the mechanism of human stefin B folding: II. Folding from GuHCl unfolded, TFE denatured, acid denatured, and acid intermediate states
    Proteins: Structure, Function, and Genetics, vol. 32, no. 3, pp. 304–313, 1998
  82. pH-induced Conformational Transitions of the Propeptide of Human Cathepsin L. A ROLE FOR A MOLTEN GLOBULE STATE IN ZYMOGEN ACTIVATION
    Journal of Biological Chemistry, vol. 273, no. 19, pp. 11498–11504, 1998
  83. Substrate inhibition of cruzipain is not affected by the C-terminal domain
    FEBS Letters, vol. 429, no. 2, pp. 129–133, 1998
  84. Crystal structure of porcine cathepsin H determined at 2.1 ? resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function
    Structure, vol. 6, no. 1, pp. 51–61, 1998
  85. Stoichiometry and heterogeneity of the pro-region chain in tetrameric human cathepsin C
    Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1382, no. 1, pp. 143–150, 1998
  86. Refolding of recombinant sulphonated procathepsin S and of reduced chicken cystatin; implications for renaturation experiments
    Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1383, no. 2, pp. 211–218, 1998
  87. Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera
    Journal of Immunological Methods, vol. 201, no. 2, pp. 165–172, 1997
  88. A fragment of the major histocompatibility complex class II – associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi
    FEBS Letters, vol. 401, no. 2-3, pp. 259–261, 1997
  89. Clinical and Experimental Metastasis, vol. 15, no. 4, pp. 368–381, 1997
  90. Crystal structure of the wild-type human procathepsin B at 2.5 Å resolution reveals the native active site of a papain-like cysteine protease zymogen
    Journal of Molecular Biology, vol. 271, no. 5, pp. 774–788, 1997
  91. Crystal structures of human procathepsin B at 3.2 and 3.3 Å resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide
    FEBS Letters, vol. 384, no. 3, pp. 211–214, 1996
  92. High-molecular-weight kininogen binds two molecules of cysteine proteinases with different rate constants
    FEBS Letters, vol. 391, no. 1-2, pp. 109–112, 1996
  93. Interaction of human cathepsin C with chicken cystatin
    FEBS Letters, vol. 392, no. 3, pp. 277–280, 1996
  94. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases
    FEBS Letters, vol. 395, no. 2-3, pp. 113–118, 1996
  95. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L
    Journal of Experimental Medicine, vol. 183, no. 4, pp. 1331–1338, 1996
  96. The Preparation of Catalytically Active Human Cathepsin B from Its Precursor Expressed in Escherichia coli in the Form of Inclusion Bodies
    European Journal of Biochemistry, vol. 229, no. 2, pp. 533–539, 1995
  97. Oligomeric Structure and Substrate Induced Inhibition of Human Cathepsin C
    Journal of Biological Chemistry, vol. 270, no. 37, pp. 21626–21631, 1995
  98. Molecular cloning and sequence analysis of human preprocathepsin C
    FEBS Letters, vol. 369, no. 2-3, pp. 326–330, 1995
  99. Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily
    FEBS Letters, vol. 370, no. 1-2, pp. 101–104, 1995
  100. The Three-dimensional Solution Structure of Human Stefin A
    Journal of Molecular Biology, vol. 246, no. 2, pp. 331–343, 1995
  101. Improved Expression and Evaluation of Polyethyleneimine Precipitation in Isolation of Recombinant Cysteine Proteinase Inhibitor Stefin B
    Protein Expression and Purification, vol. 5, no. 1, pp. 65–69, 1994
  102. Compactness of the molten globule in comparison to unfolded states as observed by size-exclusion chromatography
    Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1209, no. 1, pp. 140–143, 1994
  103. Biochemistry, vol. 33, no. 49, pp. 14800–14806, 1994
  104. Elongation on the Amino-terminal Part of Stefin B Decreases Inhibition of Cathepsin H
    European Journal of Biochemistry, vol. 224, no. 3, pp. 797–802, 1994
  105. Inhibitory Effect of Carnosolic Acid on HIV-1 Protease in Cell-Free Assays
    Journal of Natural Products, vol. 56, no. 8, pp. 1426–1430, 1993
  106. Rapid affinity chromatographic method for the isolation of human cathepsin H
    Journal of Chromatography: Biomedical Applications, vol. 615, no. 2, pp. 243–249, 1993
  107. Monoclonal antibodies to human stefin B and determination of their epitopes
    Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1164, no. 1, pp. 75–80, 1993
  108. Participation of cathepsin L on bone resorption
    FEBS Letters, vol. 321, no. 2-3, pp. 247–250, 1993
  109. The primary structure of inhibitor of cysteine proteinases from potato
    FEBS Letters, vol. 333, no. 1-2, pp. 15–20, 1993
  110. The affinity-labelling of cathepsin s with peptidyl diazomethyl ketones Comparison with the inhibition of cathepsin L and calpain
    FEBS Letters, vol. 334, no. 3, pp. 340–342, 1993
  111. Molecular cloning of a putative homolog of proline/arginine-rich antibacterial peptides from porcine bone marrow
    FEBS Letters, vol. 336, no. 2, pp. 284–288, 1993
  112. Pig leukocyte cysteine proteinase inhibitor (PLCPI), a new member of the stefin family
    FEBS Letters, vol. 336, no. 2, pp. 289–292, 1993
  113. The Structures of Native Phosphorylated Chicken Cystatin and of a Recombinant Unphosphorylated Variant in Solution
    Journal of Molecular Biology, vol. 234, no. 4, pp. 1048–1059, 1993
  114. Conformational Variability of Chicken Cystatin Comparison of Structures Determined by X-ray Diffraction and NMR Spectroscopy
    Journal of Molecular Biology, vol. 234, no. 4, pp. 1060–1069, 1993
  115. Isolation and sequence analysis of the genomic DNA fragment encoding an aspartic proteinase inhibitor homologue from potato (Solanum tuberosum L.)
    Plant Molecular Biology, vol. 20, no. 2, pp. 311–313, 1992
  116. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma
    International Journal of Cancer, vol. 50, no. 1, pp. 36–44, 1992
  117. The complete primary structure of bovine stefin B
    FEBS Letters, vol. 298, no. 2-3, pp. 237–239, 1992
  118. Calorimetric measurements of thermal denaturation of stefins A and B. Comparison to predicted thermodynamics of stefin-B unfolding
    European Journal of Biochemistry, vol. 210, no. 1, pp. 217–221, 1992
  119. Inactivation of human cystatin C and kininogen by human cathepsin D
    FEBS Letters, vol. 280, no. 2, pp. 211–215, 1991
  120. The complete amino acid sequence of bovine cathepsin S and a partial sequence of bovine cathepsin L
    FEBS Letters, vol. 283, no. 2, pp. 329–331, 1991
  121. The cystatins: Protein inhibitors of cysteine proteinases
    FEBS Letters, vol. 285, no. 2, pp. 213–219, 1991
  122. The amino acid sequence of a novel inhibitor of cathepsin D from potato
    FEBS Letters, vol. 267, no. 1, pp. 13–15, 1990
  123. Mechanism of inhibition of papain by chicken egg white cystatin Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments of the inhibitor
    FEBS Letters, vol. 243, no. 2, pp. 234–238, 1989
  124. Primary structure of a new cysteine proteinase inhibitor from pig leucocytes
    FEBS Letters, vol. 255, no. 2, pp. 211–214, 1989
  125. Stem bromelain: Amino acid sequence and implications for weak binding of cystatin
    FEBS Letters, vol. 247, no. 2, pp. 419–424, 1989
  126. Papaya proteinase IV amino acid sequence
    FEBS Letters, vol. 258, no. 1, pp. 109–112, 1989
  127. Amino acid sequences of the human kidney cathepsins H and L
    FEBS Letters, vol. 228, no. 2, pp. 341–345, 1988
  128. Cloning a synthetic gene for human stefin B and its expression in E. coli
    FEBS Letters, vol. 239, no. 1, pp. 41–44, 1988
  129. Cathepsin D inactivates cysteine proteinase inhibitors cystatins
    Biochemical and Biophysical Research Communications, vol. 154, no. 2, pp. 765–772, 1988
  130. Modification of Potentially Lethal Damage Repair by Some Intrinsic Intra- and Extracellular Agents: I. Proteinases and Proteinase Inhibitors
    International Journal of Radiation Biology, vol. 54, no. 3, pp. 461–474, 1988
  131. Human Immunodeficiency Virus Has an Aspartic-Type Protease that Can Be Inhibited by Pepstatin A
    Proceedings of the National Academy of Sciences, vol. 85, no. 18, pp. 6612–6616, 1988
  132. alpha 2-macroglobulin in the sera of patients with periodontal disease
    Journal of Clinical Periodontology, vol. 14, no. 7, pp. 403–406, 1987
  133. Bacteriological contamination of the eastern part of the Gulf of Trieste (north Adriatic) due to sewage discharge
    Chemosphere, vol. 16, no. 2-3, pp. 551–558, 1987
  134. Detection of cathepsin L-like proteinase and cathepsin D in gingival fluid
    Journal of Periodontal Research, vol. 21, no. 5, pp. 504–509, 1986
  135. Cathepsin D, L and B in inflamed human gingiva
    Journal of Periodontal Research, vol. 20, no. 5, pp. 458–466, 1985
  136. Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells
    Biochemical and Biophysical Research Communications, vol. 127, no. 3, pp. 1072–1076, 1985
  137. Crystallization of chicken egg white cystatin, a low molecular weight protein inhibitor of cysteine proteinases, and preliminary X-ray diffraction data
    Journal of Molecular Biology, vol. 181, no. 2, pp. 331–332, 1985
  138. Conformation and processing of cathepsin D
    Bioscience Reports, vol. 5, no. 10-11, pp. 957–967, 1985
  139. Evidence for the presence of large amounts of cathepsin E in rat spleen
    FEBS Letters, vol. 185, no. 2, pp. 236–238, 1985
  140. Amino acid sequence of human liver cathepsin B
    FEBS Letters, vol. 181, no. 1, pp. 169–172, 1985
  141. Species variations amongst lysosomal cysteine proteinases
    FEBS Letters, vol. 174, no. 1, pp. 123–127, 1984
  142. Human cystatin, a new protein inhibitor of cysteine proteinases
    Biochemical and Biophysical Research Communications, vol. 118, no. 1, pp. 103–109, 1984
  143. Cellulolytic complex of Aspergillus niger under conditions for citric acid production. Isolation and characterization of two ?-(1?4)-glucan hydrolases
    Applied Microbiology and Biotechnology, vol. 20, no. 5, pp. 326–330, 1984
  144. Extracellular proteinases of Claviceps purpurea. Isolation and characterization of an aspartic proteinase
    European Journal of Applied Microbiology and Biotechnology, vol. 17, no. 2, pp. 129–132, 1983
  145. Immunochemistry of leucocyte intracellular proteinase inhibitors
    Molecular Immunology, vol. 20, no. 3, pp. 263–269, 1983
  146. Serine Proteinase Inhibitors from Vipera ammodytes Venom. Isolation and Kinetic Studies
    European Journal of Biochemistry, vol. 133, no. 2, pp. 427–432, 1983
  147. An endogenous inhibitor of cysteine and serine proteinases from spleen
    FEBS Letters, vol. 138, no. 2, pp. 193–197, 1982
  148. Cathepsinogen D: characterization and activation to cathepsin D and inhibitory peptides
    FEBS Letters, vol. 132, no. 2, pp. 299–304, 1981
  149. Inactivation studies of the leucocyte inhibitor of urokinase by cathepsin D
    Molecular and Cellular Biochemistry, vol. 36, no. 3, pp. 129–134, 1981
  150. Streptomyces rimosus extracellular proteases
    European Journal of Applied Microbiology and Biotechnology, vol. 11, no. 3, pp. 166–171, 1981
  151. Streptomyces rimosus extracellular proteases
    European Journal of Applied Microbiology and Biotechnology, vol. 8, no. 1-2, pp. 81–90, 1979
  152. The isolation and characterization of trypsin and chymotrypsin inhibitors from venom V. Turk+, A. Ritonja and F. Gubenek Department of Biochemistry, J. Stefan Institute and +Department of Chemistry, University of Ljubljana, Ljubljana, Yugoslavia
    Toxicon, vol. 17, p. 195, 1979
  153. Rapid isolation of cathepsin D by affinity chromatography on the immobilized synthetic inhibitor
    FEBS Letters, vol. 71, no. 1, pp. 42–44, 1976
  154. Fractionation of Vipera ammodytes venom and seasonal variation of its composition
    Toxicon, vol. 12, no. 2, pp. 167–168, 1974
  155. Cathepsin D: Rapid Isolation by Affinity Chromatography on Haemoglobin-Agarose Resin
    European Journal of Biochemistry, vol. 48, no. 1, pp. 245–254, 1974
  156. Molecular weight of cathepsins from different animal organs
    Die Naturwissenschaften, vol. 53, no. 20, pp. 528–528, 1966